Stockscreener 앱 받기
203.46
3.13%
6.18
시간 외 거래:
202.93
-0.53
-0.26%
Moderna Inc 주식(MRNA)의 최신 뉴스
The first mRNA flu vaccine is now available for older adults. Here’s what to know - KCRA
Biotech Stocks To Follow TodaySeptember 27th - MarketBeat
Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem - GuruFocus
MODERNA INC (MRNA-USD.SW) - Yahoo! Finance Canada
Top Healthcare Stocks To ConsiderSeptember 26th - MarketBeat
Moderna Stock (MRNA) Opinions on Cancer Vaccine Phase 3 Success - Quiver Quantitative
Moderna CEO’s Realistic Approach to Innovation - WSJ
Top Biotech Stocks To Add to Your WatchlistSeptember 26th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Moderna Inc Lobbyists, 2026 - OpenSecrets
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Stock Traders Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA) - MarketBeat
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Yahoo Finance
Promising Healthcare Stocks To ResearchSeptember 25th - MarketBeat
Moderna stock last at USD 199.29 in New York trading - ad-hoc-news.de
Moderna Stock Reached New 52-Week High: What's Happening? - Benzinga
Moderna Rallies 39 Percent as Small Cap Healthcare Stocks Surge - SuaraGarut.ID
Bernstein reiterates Moderna stock rating on mRNA platform progress - Investing.com
Bernstein reiterates Moderna stock rating on mRNA platform progress By Investing.com - Investing.com Canada
Moderna Stock Forecast: MRNA Hits 52-Week High as Melanoma Vaccine Drives Rally - FXLeaders
Moderna stock gains 6.98 percent near its 52-week high - AD HOC NEWS
MRNA Looks 710.7% Overvalued on GF Value™ - GuruFocus
Moderna, Inc. Stock Analysis: Momentum Builds Amid Overbought Signals - The Cryptonomist
Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24. - TIKR.com
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Moderna stock heads into the open after a 6.98 percent gain - AD HOC NEWS
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better - Yahoo Finance
Moderna Stock Trends After HoursModerna (NASDAQ:MRNA), Merck & Co (NYSE:MRK) - Benzinga
Why is Moderna (MRNA) Stock Trending After Hours? - TradingView
Moderna Inc. R (0QF.DU) stock price, news, quote and history - Yahoo Finance Australia
$Moderna (MRNA.US)$ thanks - Moomoo
Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak - Yahoo Finance
From $63 To $195: Moderna’s Two-Month Rerating Isn’t Done - Yahoo Finance
Moderna Rises as Cancer-Vaccine Momentum and Pipeline Visibility Stay in Focus - Quiver Quantitative
Moderna, Inc. (MRNA) Options ChainYahoo Finance - Yahoo! Finance Canada
Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know - TradingKey
Moderna's View of the Global Pharma Industry - WSJ
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
A New Cancer Vaccine Shows Promise for Melanoma—Here’s What Doctors Know So Far - elle.com
Moderna stock trades below its 52-week high before cancer data - AD HOC NEWS
Dear Doctor: Should I hold off on my flu shot until I'm eligible for the new version? - syracuse.com
Biotech Stocks At 52-Week HighsTKNO, MRNA, ATRC, ILMN - RTTNews
Nykredit A S Acquires New Holdings in Moderna, Inc. $MRNA - MarketBeat
Engineers Gate Manager LP Cuts Holdings in Moderna, Inc. $MRNA - MarketBeat
Moderna Inc (MRNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Moderna stock gains 4.5 percent ahead of the open - ad-hoc-news.de
Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today? - Yahoo Finance
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines - Barron's
Moderna stock rises 5.6 percent at the close - AD HOC NEWS
Healthcare Stocks Fall -- Healthcare Roundup - marketscreener.com
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID - TradingView
MRNA: Broad mRNA platform advances, led by oncology and rare disease innovation, drive future growth - TradingView
Moderna Stock Forecast: MRNA Hits $187 as Melanoma Vaccine Fuels Rally - fxleaders.com
Moderna’s mRNA flu shot hits the target - Science News
Moderna stock rises 5.6 percent on melanoma data - AD HOC NEWS
Moderna stock gains 5.6 percent ahead of the open - AD HOC NEWS
Moderna stock gains 5.6 percent as melanoma data approaches - AD HOC NEWS
Moderna (MRNA) Co Founder Joined An AI Drug Discovery Company - simplywall.st
Moderna (NASDAQ:MRNA) Trading Up 5.6%What's Next? - MarketBeat
Moderna, Inc.'s stock price soars to $182.56, marking a robust 5.56% increase: A lucrative investment opportunity - Smartkarma
Moderna stock gains 5.16 percent after the close - AD HOC NEWS
Moderna's Surge Faces Wall Street Skepticism as Analysts Question Cancer Vaccine Rally - finance.biggo.com
Was Moderna Stock's Cancer Vaccine Run Visible In Advance? - finance.yahoo.com
Was Moderna Stock’s Cancer Vaccine Run Visible In Advance? - trefis.com
Moderna Inc Stock (MRNA) Moved Up by 5.16% on Sep 22: A Full Analysis - TradingKey
Moderna Up Over 7%, On Track for Highest Close Since January 2023 -- Data Talk - moomoo.com
Should You Buy Moderna Stock? Why Many Wall Street Analysts Say "No." - The Globe and Mail
Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up? - Yahoo Finance
UBS reiterates Moderna stock rating ahead of melanoma data - Investing.com
How the Merck-Moderna mRNA melanoma vaccine is built per patient - qz.com
0.23%
1.36%
자본화:
|
볼륨(24시간):